Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation

Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation

Side effects were from the central nervous system and the gastrointestinal tract, which clinically come out in hypersensitivity reactions (56%), convulsions (7%), headache, dizziness (14%), nausea, vomiting (21%) and diarrhea (2%).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e78-e78
Hauptverfasser: Kulushova, G.A, Zurdinov, A.Z, Moldoisaeva, S.R
Format: Artikel
Sprache:eng
Schlagworte:
Drugs
Internal Medicine
Medical Education
Side effects
Tuberculosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e78
container_issue 8
container_start_page e78
container_title Clinical therapeutics
container_volume 37
creator Kulushova, G.A
Zurdinov, A.Z
Moldoisaeva, S.R
description Side effects were from the central nervous system and the gastrointestinal tract, which clinically come out in hypersensitivity reactions (56%), convulsions (7%), headache, dizziness (14%), nausea, vomiting (21%) and diarrhea (2%).
doi_str_mv 10.1016/j.clinthera.2015.05.225
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1693851398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0149291815005329</els_id><sourcerecordid>3735358081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2385-fa0c11c82ff278f642ee3fcccd287048249cb8eab7333e86a9d3468c0556aa3c3</originalsourceid><addsrcrecordid>eNqNkc1Lw0AQxRdRsFb_BgOeE_cjm-x6EKT4LViwgrdlO520W9Ok7iaF-tebUFHw5Gkub96b-T1CThlNGGXZ-TKB0lXNAr1NOGUyoTLhXO6RAVO5jhlL3_bJgLJUx1wzdUiOQlhSSoWWfEAexgvrVxbqjZu70laAkauix62fbz-jSTtFD21ZBxeicTstHURjX8-9XV1E0HqPVRMF17S2cXV1TA4KWwY8-Z5D8npzPRndxU_Pt_ejq6cYuFAyLiwFxkDxouC5KrKUI4oCAGZc5TRVPNUwVWinuRACVWb1TKSZAiplZq0AMSRnO9-1rz9aDI1Z1q2vukjDMt1FMKFVp8p3KvB1CB4Ls_ZuZf3WMGp6cGZpfsCZHpyh0nTgus2r3SZ2T2wcehPAYUdm5jxCY2a1-4fH5R-PXufAlu-4xfB7sAncUPPS19O3wySlUnAtvgBbwJDr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693851398</pqid></control><display><type>article</type><title>Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation</title><source>Elsevier ScienceDirect Journals</source><creator>Kulushova, G.A ; Zurdinov, A.Z ; Moldoisaeva, S.R</creator><creatorcontrib>Kulushova, G.A ; Zurdinov, A.Z ; Moldoisaeva, S.R</creatorcontrib><description>Side effects were from the central nervous system and the gastrointestinal tract, which clinically come out in hypersensitivity reactions (56%), convulsions (7%), headache, dizziness (14%), nausea, vomiting (21%) and diarrhea (2%).</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2015.05.225</identifier><language>eng</language><publisher>Bridgewater: Elsevier Inc</publisher><subject>Drugs ; Internal Medicine ; Medical Education ; Side effects ; Tuberculosis</subject><ispartof>Clinical therapeutics, 2015-08, Vol.37 (8), p.e78-e78</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited Aug 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0149291815005329$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Kulushova, G.A</creatorcontrib><creatorcontrib>Zurdinov, A.Z</creatorcontrib><creatorcontrib>Moldoisaeva, S.R</creatorcontrib><title>Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation</title><title>Clinical therapeutics</title><description>Side effects were from the central nervous system and the gastrointestinal tract, which clinically come out in hypersensitivity reactions (56%), convulsions (7%), headache, dizziness (14%), nausea, vomiting (21%) and diarrhea (2%).</description><subject>Drugs</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><subject>Side effects</subject><subject>Tuberculosis</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkc1Lw0AQxRdRsFb_BgOeE_cjm-x6EKT4LViwgrdlO520W9Ok7iaF-tebUFHw5Gkub96b-T1CThlNGGXZ-TKB0lXNAr1NOGUyoTLhXO6RAVO5jhlL3_bJgLJUx1wzdUiOQlhSSoWWfEAexgvrVxbqjZu70laAkauix62fbz-jSTtFD21ZBxeicTstHURjX8-9XV1E0HqPVRMF17S2cXV1TA4KWwY8-Z5D8npzPRndxU_Pt_ejq6cYuFAyLiwFxkDxouC5KrKUI4oCAGZc5TRVPNUwVWinuRACVWb1TKSZAiplZq0AMSRnO9-1rz9aDI1Z1q2vukjDMt1FMKFVp8p3KvB1CB4Ls_ZuZf3WMGp6cGZpfsCZHpyh0nTgus2r3SZ2T2wcehPAYUdm5jxCY2a1-4fH5R-PXufAlu-4xfB7sAncUPPS19O3wySlUnAtvgBbwJDr</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Kulushova, G.A</creator><creator>Zurdinov, A.Z</creator><creator>Moldoisaeva, S.R</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20150801</creationdate><title>Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation</title><author>Kulushova, G.A ; Zurdinov, A.Z ; Moldoisaeva, S.R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2385-fa0c11c82ff278f642ee3fcccd287048249cb8eab7333e86a9d3468c0556aa3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Drugs</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><topic>Side effects</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulushova, G.A</creatorcontrib><creatorcontrib>Zurdinov, A.Z</creatorcontrib><creatorcontrib>Moldoisaeva, S.R</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulushova, G.A</au><au>Zurdinov, A.Z</au><au>Moldoisaeva, S.R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation</atitle><jtitle>Clinical therapeutics</jtitle><date>2015-08-01</date><risdate>2015</risdate><volume>37</volume><issue>8</issue><spage>e78</spage><epage>e78</epage><pages>e78-e78</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Side effects were from the central nervous system and the gastrointestinal tract, which clinically come out in hypersensitivity reactions (56%), convulsions (7%), headache, dizziness (14%), nausea, vomiting (21%) and diarrhea (2%).</abstract><cop>Bridgewater</cop><pub>Elsevier Inc</pub><doi>10.1016/j.clinthera.2015.05.225</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-2918
ispartof Clinical therapeutics, 2015-08, Vol.37 (8), p.e78-e78
issn 0149-2918
1879-114X
language eng
recordid cdi_proquest_journals_1693851398
source Elsevier ScienceDirect Journals
subjects Drugs
Internal Medicine
Medical Education
Side effects
Tuberculosis
title Pharmacovigilance in Kyrgyz Tuberculosis Public Program: current situation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A35%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacovigilance%20in%20Kyrgyz%20Tuberculosis%20Public%20Program:%20current%20situation&rft.jtitle=Clinical%20therapeutics&rft.au=Kulushova,%20G.A&rft.date=2015-08-01&rft.volume=37&rft.issue=8&rft.spage=e78&rft.epage=e78&rft.pages=e78-e78&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2015.05.225&rft_dat=%3Cproquest_cross%3E3735358081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693851398&rft_id=info:pmid/&rft_els_id=1_s2_0_S0149291815005329&rfr_iscdi=true